Built on science. Focused on clinical impact.
epsilonDx combines scientific innovation with a clear clinical goal: enabling faster, better-informed antibiotic decisions in settings where uncertainty can have serious consequences.
Clinical relevance
We focus on solutions that address real decision-making challenges in infectious disease management.
Scientific foundation
Our approach is grounded in phenotypic diagnostics and supported by ongoing scientific and technical development.
Development pathway
epsilonDx is advancing its platform with a strong emphasis on robustness, usability, and future clinical adoption.
O. Riester, L. Kaiser, S. Laufer, H.-P. Deigner, Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype. Adv. Sci.2024, 11, 2308806. https://doi.org/10.1002/advs.202308806